CTL Amedica

CTL Amedica is a medical device design, development, and manufacturing company specializing in spinal fusion and fixation implants. The company holds an exclusive global position as the provider of silicon nitride (Si₃N₄) implants for spine surgery. Their core product portfolio incorporates proprietary bioactive osteogenic materials, including NITRO™ silicon nitride technology and TiCro® machined metal surface architecture, combined with patented pedicle screw housing designs. Clinical data indicates silicon nitride implants demonstrate 2–3 times more bone formation, 2–6 times better osseointegration, and 8–30 times reduced bacterial association compared to PEEK or titanium alternatives. The company operates with a robust R&D team focused on biomaterials innovation and surface technologies. Product lines are named after renowned artists and include comprehensive spinal fusion systems designed for universal surgical applications. CTL Amedica serves a global market, providing professional training and comprehensive customer support. The company emphasizes cost-effective, high-quality surgical solutions backed by a differentiated patent portfolio. Manufacturing and design capabilities support rapid commercialization for evolving spinal care technologies.